Carlsmed, Inc. (CARL) stock
CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30123% above fair value
$17.42+0.20 (+1.16%)
Close on Nov 20, 2026Market cap $475.61MP/E –Yield –
Carlsmed gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Carlsmed's gross profit for the twelve months ending Jun 30, 2026 was $48.50M, up 71.2% year over year. For fiscal 2025 it was $38.04M, up 89.7% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.04M | +89.7% |
| FY2024 | Dec 31, 2024 | $20.05M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $14.54M | +64.0% |
| Q1 FY2026 | Mar 31, 2026 | $12.43M | +62.7% |
| Q4 FY2025 | Dec 31, 2025 | $11.61M | +65.3% |
| Q3 FY2025 | Sep 30, 2025 | $9.93M | +106.9% |
| Q2 FY2025 | Jun 30, 2025 | $8.87M | +94.4% |
| Q1 FY2025 | Mar 31, 2025 | $7.64M | – |
| Q4 FY2024 | Dec 31, 2024 | $7.02M | – |
| Q3 FY2024 | Sep 30, 2024 | $4.80M | – |
| Q2 FY2024 | Jun 30, 2024 | $4.56M | – |
See a number that looks wrong?